Marketing Agreements in the Health Care Equipment & Supplies Industry
14 Contracts & Agreements
- BIOMIMETIC THERAPEUTICS, INC. (1 contract)
- CORNERSTONE THERAPEUTICS INC (5)
- Cytosorbents Corp (1)
- LivaNova (1)
- Oxford Immunotec Global PLC (1)
- Ra Medical Systems, Inc. (3)
- RTI SURGICAL, INC. (1)
- TearLab Corp (1)
- Addendum One dated May 27, 2022 to the Stereotaxis Marketing Agreement (Ra Medical Systems, Inc., Filed With SEC on March 28, 2023)
- Extension Agreement dated January 11, 2022 to the Stereotaxis Marketing Agreement (Ra Medical Systems, Inc., Filed With SEC on March 28, 2023)
- Joint Marketing Agreement dated January 19, 2021 with Stereotaxis, Inc. (the Stereotaxis Marketing Agreement) (Ra Medical Systems, Inc., Filed With SEC on March 28, 2023)
- Marketing Agreement, by and between the Company and Fresenius Medical Care Deutschland GmbH, dated as of August 1, 2022 (Cytosorbents Corp, Filed With SEC on November 3, 2022)
- Roy Khoury Confirmation Letter as President International Commercial and SVP, Global Strategic Marketing (LivaNova, Filed With SEC on July 29, 2020)
- Letter Agreement re: Marketing Approval, dated June 28, 2018, by and between RTI Surgical, Inc. and Biomet 3i, LLC (RTI SURGICAL, INC., Filed With SEC on March 5, 2019)
- AMENDMENT TO MARKETING AUTHORIZATION HOLDER AGREEMENT (“Amendment 3”) (Oxford Immunotec Global PLC, Filed With SEC on July 28, 2017)
- Cooperative Marketing Agreement with AMO Canada Company and Science with Vision, Inc., dated August 30, 2010 (TearLab Corp, Filed With SEC on September 3, 2010)
- EX-10.32 Amendment No. 1, dated December 18, 2009, to Supply and Marketing Agreement (CORNERSTONE THERAPEUTICS INC, Filed With SEC on March 4, 2010)
- Ex-10.1 Amendment No. 2, dated May 4, 2009, to Co-Promotion and Marketing Services Agreement with Dey, L.P (CORNERSTONE THERAPEUTICS INC, Filed With SEC on May 7, 2009)
- Ex-10.18 Supply and Marketing Agreement between Sovereign Pharmaceuticals, LTD and Aristos Pharmaceuticals, Inc. dated May 1, 2008 (CORNERSTONE THERAPEUTICS INC, Filed With SEC on November 5, 2008)
- AGREEMENT TERMINATING RESEARCH, DEVELOPMENT AND MARKETING AGREEMENT (BIOMIMETIC THERAPEUTICS, INC., Filed With SEC on March 12, 2008)
- Ex-10.5 Amendment No. 1 to Co-Promotion and Marketing Services Agreement (CORNERSTONE THERAPEUTICS INC, Filed With SEC on August 9, 2007)
- EX-10.2 Co-Promotion and Marketing Services Agreement by and between the Registrant and Dey, L.P. dated March 13, 2007 (CORNERSTONE THERAPEUTICS INC, Filed With SEC on May 10, 2007)
